癌症疫苗治疗方法:局限性和有效性-一篇文献综述
Mariusz Kaczmarek1,2, Justyna Poznańska3, Filip Fechner3
1Department of Medical Biotechnology, Poznan University of Medical Sciences, 61-866 Poznań, Poland.
Cells
|September 8, 2023
概括
针对瘤微环境的癌症疫苗显示出激活免疫系统对抗癌症的潜力. 尽管存在诸如瘤异质性等挑战,但正在进行的研究旨在优化这些疗法,以获得更好的临床结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 针对瘤微环境 (TME) 的治疗性癌症疫苗正在引起人们对利用免疫系统对抗癌症的兴趣.
- 尽管有超过一个世纪的研究,癌症疫苗的有效性,特别是在晚期,受到TME异质性,免疫抑制细胞和瘤逃逸的限制.
- 患者的免疫变异性和抗原识别挑战也会影响治疗的成功.
研究的目的:
- 审查癌症疫苗的机制,输送方法和辅助剂.
- 检查癌症疫苗接种免疫疗法的历史发展和当前状况.
- 分析不同类型疫苗的局限性和有效性,以便在未来开发.
主要方法:
- 关于癌症疫苗研究的综合文献综述.
- 对临床前和临床研究结果的分析.
- 探索针对TME的疫苗策略.
主要成果:
- 瘤微环境向癌症疫苗在临床前和临床研究中显示出潜力.
- 这些疗法可能为现有的癌症治疗提供有价值的补充.
- 优化疫苗的设计,输送和识别预测生物标志物至关重要.
结论:
- 针对TME的癌症疫苗疗法代表了瘤学的有希望的前沿.
- 为了克服现有的局限性并改善患者反应,进一步的研究是必不可少的.
- 这些疫苗在与当前的治疗方式相结合时,有可能成为治疗选择.
相关概念视频
Cancer Vaccines
399
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
399
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Tumor Immunotherapy
554
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


